Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
Legend Biotech (NASDAQ: LEGN), a global cell therapy leader, has announced its participation in the upcoming Morgan Stanley Global Healthcare Conference. The company's CEO, Dr. Ying Huang, will engage in a fireside chat on September 9, 2025, at 4:05 p.m. ET in New York.
Investors can access the live webcast through Legend Biotech's Investor Relations website section, with a replay becoming available approximately 48 hours after the event.
Legend Biotech (NASDAQ: LEGN), leader globale nelle terapie cellulari, ha annunciato la propria partecipazione alla prossima Morgan Stanley Global Healthcare Conference. L'amministratore delegato, Dr. Ying Huang, parteciperà a un fireside chat il 9 settembre 2025 alle 16:05 ET a New York.
Gli investitori potranno seguire la diretta via webcast nella sezione Investor Relations del sito di Legend Biotech; la registrazione sarà disponibile in replay circa 48 ore dopo l'evento.
Legend Biotech (NASDAQ: LEGN), líder mundial en terapias celulares, ha anunciado su participación en la próxima Morgan Stanley Global Healthcare Conference. La directora ejecutiva, Dr. Ying Huang, participará en un fireside chat el 9 de septiembre de 2025 a las 4:05 p.m. ET en Nueva York.
Los inversores podrán acceder a la retransmisión en directo a través de la sección de Investor Relations del sitio web de Legend Biotech; la grabación estará disponible aproximadamente 48 horas después del evento.
Legend Biotech (NASDAQ: LEGN), 글로벌 세포 치료 선도기업이 다가오는 Morgan Stanley Global Healthcare Conference에 참가한다고 발표했습니다. 최고경영자 Dr. Ying Huang가 2025년 9월 9일 오후 4시 05분(동부시간) 뉴욕에서 진행되는 파이어사이드 채팅에 참석합니다.
투자자들은 Legend Biotech 투자자 관계(Investor Relations) 웹사이트 섹션을 통해 라이브 웹캐스트를 시청할 수 있으며, 이벤트 종료 약 48시간 후에 재방송(리플레이)이 제공됩니다.
Legend Biotech (NASDAQ: LEGN), leader mondial des thérapies cellulaires, a annoncé sa participation à la prochaine Morgan Stanley Global Healthcare Conference. La directrice générale, Dr. Ying Huang, interviendra lors d'un fireside chat le 9 septembre 2025 à 16h05 ET à New York.
Les investisseurs pourront suivre le webcast en direct via la section Relations Investisseurs du site de Legend Biotech ; un replay sera disponible environ 48 heures après l'événement.
Legend Biotech (NASDAQ: LEGN), ein weltweit führendes Unternehmen im Bereich Zelltherapien, hat seine Teilnahme an der bevorstehenden Morgan Stanley Global Healthcare Conference angekündigt. Die Geschäftsführerin, Dr. Ying Huang, wird am 9. September 2025 um 16:05 Uhr ET in New York an einem Fireside-Chat teilnehmen.
Investorinnen und Investoren können das Live-Webcast über den Investor-Relations-Bereich der Legend Biotech-Website verfolgen; ein Replay wird etwa 48 Stunden nach der Veranstaltung verfügbar sein.
- None.
- None.
SOMERSET, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 9, 2025, at 4:05 p.m. ET.
The live webcast will be available to investors and other interested parties by accessing the Investor Relations section of Legend’s website. The webcast replay will be available approximately 48 hours after the webcast.
ABOUT LEGEND BIOTECH
With over 2,800 employees, Legend Biotech is the largest standalone cell therapy company and a pioneer in treatments that change cancer care forever. The company is at the forefront of the CAR-T cell therapy revolution with CARVYKTI®, a one-time treatment for relapsed or refractory multiple myeloma, which it develops and markets with collaborator Johnson & Johnson. Headquartered in the US, Legend is building an end-to-end cell therapy company by expanding its leadership to maximize CARVYKTI’s patient access and therapeutic potential. From this platform, the company plans to drive future innovation across its pipeline of cutting-edge cell therapy modalities.
Learn more at www.legendbiotech.com and follow us on X (formerly Twitter) and LinkedIn.
INVESTOR CONTACT:
Jessie Yeung
Tel: (732) 956-8271
jessie.yeung@legendbiotech.com
PRESS CONTACT:
Mary Ann Ondish
Tel: (914) 552-4625
media@legendbiotech.com
FAQ
When is Legend Biotech (LEGN) presenting at the Morgan Stanley Healthcare Conference 2025?
Who will represent Legend Biotech at the Morgan Stanley Conference 2025?
How can investors watch Legend Biotech's Morgan Stanley Conference presentation?
What type of presentation will Legend Biotech (LEGN) give at the Morgan Stanley Conference?
